Dynamic Metabolomics Study of the Bile Acid Pathway During Perioperative Primary Hepatic Carcinoma Following Liver Transplantation

Overview

Journal Ann Transplant

Specialty General Surgery

Date 2020 Jun 24

PMID 32572018

Citations 3

Authors

Weiguo Sui

Qing Gan

Fuhua Liu

Minglin Ou

Bingguo Wang

Songbai Liao

Liusheng Lai

Huaizhou Chen

Ming Yang

Yong Dai

Affiliations

Soon will be listed here.

Abstract

BACKGROUND There are many situations of abnormal metabolism influencing liver graft function. This study aims to provide data for the development of liver function recovery after liver transplantation by dynamically analyzing metabolites of bile acids pathway in serum. MATERIAL AND METHODS A comprehensive metabolomics profiling of serum of 9 liver transplantation patients before transplantation, on the 1st, 3rd, and 7th days after liver transplantation, and healthy individuals were performed by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). Multivariate data and dynamic analysis were used to search for biomarkers between the metabolomics profiles present in perioperative liver transplantation and normal controls. RESULTS Thirty-three differential endogenous metabolites were screened by the threshold of variable importance in the projection (VIP) from an orthogonal partial least square discriminant analysis (OPLS-DA) greater than 1.0, q-value <0.05, and fold change (FC) ≤0.8 or ≥1.2 between the preoperative group and the normal controls in negative mode. The metabolite intensities of taurocholic acid, taurochenodeoxycholic acid, chenodeoxycholic acid glycine conjugate, and glycocholic acid pre-transplantation were significantly higher than those of normal controls. The average metabolite intensities of taurocholic acid and taurochenodesoxycholic acid on the first day after liver transplantation were lower than those observed pre-transplantation. The average metabolite intensities on day 3 after liver transplantation showed a sudden increase and then decreased after 7 postoperative days. The average metabolite intensities of glycocholic acid and chenodeoxycholic acid glycine conjugate showed an increasing trend on the 1st, 3rd, and 7th days after liver transplantation. CONCLUSIONS Use of taurocholic acid and taurochenodeoxycholic acid-related bile secretion, liver regeneration, and de novo bile acid synthesis may help clinical evaluation and provide data for the development of liver function recovery after liver transplantation.

Citing Articles

Clinical effect of hepatic artery interventional embolization and chemotherapy and its influence on P16 protein expression in patients with liver cancer.

Zhang J, Liu P, Xie Y Clin Transl Oncol. 2024; 27(2):642-649.

PMID: 39088187 DOI: 10.1007/s12094-024-03631-0.

Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation.

Liu Z, Xu J, Que S, Geng L, Zhou L, Mardinoglu A J Clin Transl Hepatol. 2022; 10(2):363-373.

PMID: 35528975 PMC: 9039708. DOI: 10.14218/JCTH.2021.00219.

Untargeted metabolomics analysis of esophageal squamous cell cancer progression.

Yang T, Hui R, Nouws J, Sauler M, Zeng T, Wu Q J Transl Med. 2022; 20(1):127.

PMID: 35287685 PMC: 8919643. DOI: 10.1186/s12967-022-03311-z.

References

Mapstone M, Cheema A, Fiandaca M, Zhong X, Mhyre T, MacArthur L . Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014; 20(4):415-8. PMC: 5360460. DOI: 10.1038/nm.3466. View

Citores M, Lucena J, De la Fuente S, Cuervas-Mons V . Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. World J Hepatol. 2019; 11(1):50-64. PMC: 6354126. DOI: 10.4254/wjh.v11.i1.50. View

Hagenbuch B, Meier P . Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Semin Liver Dis. 1996; 16(2):129-36. DOI: 10.1055/s-2007-1007226. View

Crabtree G, Gogos J . Role of Endogenous Metabolite Alterations in Neuropsychiatric Disease. ACS Chem Neurosci. 2018; 9(9):2101-2113. DOI: 10.1021/acschemneuro.8b00145. View

Golob-Schwarzl N, Krassnig S, Toeglhofer A, Park Y, Gogg-Kamerer M, Vierlinger K . New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors. Eur J Cancer. 2017; 83:56-70. DOI: 10.1016/j.ejca.2017.06.003. View

Cortes M, Pareja E, Garcia-Canaveras J, Donato M, Montero S, Mir J . Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction. J Hepatol. 2014; 61(3):564-74. DOI: 10.1016/j.jhep.2014.04.023. View

Saghatelian A, Cravatt B . Global strategies to integrate the proteome and metabolome. Curr Opin Chem Biol. 2005; 9(1):62-8. DOI: 10.1016/j.cbpa.2004.12.004. View

Agellon L, Torchia E . Intracellular transport of bile acids. Biochim Biophys Acta. 2000; 1486(1):198-209. DOI: 10.1016/s1388-1981(00)00057-3. View

Marsh J, Geller D, Finkelstein S, Donaldson J, Dvorchik I . Role of liver transplantation for hepatobiliary malignant disorders. Lancet Oncol. 2004; 5(8):480-8. DOI: 10.1016/S1470-2045(04)01527-X. View

10.

Wang T, Larson M, Vasan R, Cheng S, Rhee E, McCabe E . Metabolite profiles and the risk of developing diabetes. Nat Med. 2011; 17(4):448-53. PMC: 3126616. DOI: 10.1038/nm.2307. View

11.

Lin W, Zhang J, Liu Y, Wu R, Yang H, Hu X . Studies on diagnostic biomarkers and therapeutic mechanism of Alzheimer's disease through metabolomics and hippocampal proteomics. Eur J Pharm Sci. 2017; 105:119-126. DOI: 10.1016/j.ejps.2017.05.003. View

12.

Marsman W, Wiesner R, Rodriguez L, Batts K, Porayko M, Hay J . Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation. 1996; 62(9):1246-51. DOI: 10.1097/00007890-199611150-00011. View

13.

Chen J, Wang W, Lv S, Yin P, Zhao X, Lu X . Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal Chim Acta. 2009; 650(1):3-9. DOI: 10.1016/j.aca.2009.03.039. View

14.

Perera M, Higdon R, Richards D, Silva M, Murphy N, Kolker E . Biomarker differences between cadaveric grafts used in human orthotopic liver transplantation as identified by coulometric electrochemical array detection (CEAD) metabolomics. OMICS. 2014; 18(12):767-77. DOI: 10.1089/omi.2014.0094. View

15.

Vilca Melendez H, Rela M, Setchell K, Murphy G, Heaton N . Bile acids analysis: a tool to assess graft function in human liver transplantation. Transpl Int. 2004; 17(6):286-92. DOI: 10.1007/s00147-004-0719-2. View

16.

Singh S, Nasa V, Tandon M . Perioperative monitoring in liver transplant patients. J Clin Exp Hepatol. 2015; 2(3):271-8. PMC: 3940305. DOI: 10.1016/j.jceh.2012.06.003. View

17.

Sui W, Gan Q, Liu F, Chen H, Liu J, Dai Y . The differentially expressed circular ribonucleic acids of primary hepatic carcinoma following liver transplantation as new diagnostic biomarkers for primary hepatic carcinoma. Tumour Biol. 2018; 40(4):1010428318766928. DOI: 10.1177/1010428318766928. View

18.

Zhang A, Sun H, Han Y, Yan G, Wang X . Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system. PLoS One. 2013; 8(5):e64381. PMC: 3655955. DOI: 10.1371/journal.pone.0064381. View

19.

Ferraris R, Colombatti G, Fiorentini M, Carosso R, Arossa W, De La Pierre M . Diagnostic value of serum bile acids and routine liver function tests in hepatobiliary diseases. Sensitivity, specificity, and predictive value. Dig Dis Sci. 1983; 28(2):129-36. DOI: 10.1007/BF01315142. View

20.

Legido-Quigley C, McDermott L, Vilca-Melendez H, Murphy G, Heaton N, Lindon J . Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation. Electrophoresis. 2011; 32(15):2063-70. DOI: 10.1002/elps.201000512. View